Miromatrix Medical Inc. Operating Expenses
Miromatrix Medical Inc. reported Operating Expenses of $6.52 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-11-14
- Miromatrix Medical Inc. operating expenses for the quarter ending 2023-09-30 was $6.52M, a 14.68% decline year-over-year.
- Miromatrix Medical Inc. operating expenses for the quarter ending 2023-06-30 was $6.57M, a 19.00% decline year-over-year.
- Miromatrix Medical Inc. operating expenses for the quarter ending 2023-03-31 was $7.98M, a 12.81% increase year-over-year.
- Miromatrix Medical Inc. operating expenses for the quarter ending 2022-12-31 was $7.99M, a 49.33% increase year-over-year.
- Miromatrix Medical Inc. operating expenses for fiscal 2022 was $30.82M, a 86.80% increase from fiscal 2021.
- Miromatrix Medical Inc. operating expenses for fiscal 2021 was $16.50M, a 68.26% increase from fiscal 2020.
- Miromatrix Medical Inc. operating expenses for fiscal 2020 was $9.81M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | $6.52M 10-Q · filed 2023-11-14 | $13.09M derived: sum of 2 quarters · filed 2023-11-14 | $21.08M 10-Q · filed 2023-11-14 | $29.06M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-06-30 | $6.57M 10-Q · filed 2023-08-14 | $14.55M 10-Q · filed 2023-08-14 | $22.54M derived: sum of 3 quarters · filed 2023-08-14 | $30.18M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-03-31 | $7.98M 10-Q · filed 2023-05-11 | $15.97M derived: sum of 2 quarters · filed 2023-05-11 | $23.61M derived: sum of 3 quarters · filed 2023-11-14 | $31.72M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-12-31 | $7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $15.63M derived: sum of 2 quarters · filed 2023-11-14 | $23.74M derived: sum of 3 quarters · filed 2023-11-14 | $30.82M 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $7.64M 10-Q · filed 2023-11-14 | $15.76M derived: sum of 2 quarters · filed 2023-11-14 | $22.83M 10-Q · filed 2023-11-14 | $28.18M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $8.11M 10-Q · filed 2023-08-14 | $15.19M 10-Q · filed 2023-08-14 | $20.54M derived: sum of 3 quarters · filed 2023-08-14 | $25.63M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $7.08M 10-Q · filed 2023-05-11 | $7.07M 10-Q · filed 2022-05-16 | $12.42M derived: sum of 2 quarters · filed 2023-05-11 | $17.52M derived: sum of 3 quarters · filed 2023-05-11 | $20.97M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $10.44M derived: sum of 2 quarters · filed 2023-03-31 | $13.90M derived: sum of 3 quarters · filed 2023-03-31 | $16.50M 10-K · filed 2023-03-31 | $16.49M 10-K · filed 2022-03-30 | |
| 2021-09-30 | $5.09M 10-Q · filed 2022-11-14 | $8.55M derived: sum of 2 quarters · filed 2022-11-14 | $11.15M 10-Q · filed 2022-11-14 | $13.39M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $3.46M 10-Q · filed 2022-08-15 | $6.06M 10-Q · filed 2022-08-15 | $8.30M derived: sum of 3 quarters · filed 2022-08-15 | $10.77M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $2.60M 10-Q · filed 2022-05-16 | $4.84M derived: sum of 2 quarters · filed 2022-05-16 | $7.31M derived: sum of 3 quarters · filed 2022-05-16 | $10.07M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.71M derived: sum of 2 quarters · filed 2022-03-30 | $7.46M derived: sum of 3 quarters · filed 2022-03-30 | $9.81M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $2.47M 10-Q · filed 2021-11-15 | $5.23M derived: sum of 2 quarters · filed 2021-11-15 | $7.57M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $2.76M 10-Q · filed 2021-08-12 | $5.10M 10-Q · filed 2021-08-12 |